Table 2

Clinicopathological profiles and detection of UP-II-Positive cells in peripheral blood of patients with loco-regional lymph node or distant organ metastases

Patient No.Age/SexPrimary siteGroupSite of metastasis diameterEstimated volume of metastatic tumor (cc)UP-II- positive cells
964 /FPaLNPelvic LN, 20 mm12+
1087 /MULNMicrometastasis of pelvic LN<1
1156 /MULNPara-aortic-mediastinum LN, >50 mm120+
1751 /MBLNMicrometastasis to pelvic LN<1
5981 /FULNPelvic LN (direct invasion), 70 mm50
472 /MUDMediastinum, <50 mm× 2; para-aortic LN, <50 mm80+
670 /MBDLung (multiple), <30 mm130+
755 /MBDPleura, 40 mm× 5; brain, 20 mm× 1; vertebra Th5-7120+
1263 /MUDPleura, 30 mm; pubic bone, 50 mm90+
1367 /MBDLung (multiple), >50 mm180
873 /MBDLung (multiple), <30 mm130+
5346 /MBDLiver (multiple), <20 mm; bone, 40 mm90
5871 /FBDLiver (solitary), >50 mm120+
  • a P, renal pelvis; U, ureter; B, bladder; LN, Lymph node metastasis; D, distant metastasis.